Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerate Improvement in Multiple Myeloma for Newly Diagnosed Transplant-Eligible Patients

NCT07671287 is registered in ClinicalTrials.gov with University of Heidelberg Medical Center as lead sponsor.

NCT NCT07671287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07671287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerate Improvement in Multiple Myeloma for Newly Diagnosed Transplant-Eligible Patients
Lead sponsor
University of Heidelberg Medical Center
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
January 30, 2033
Enrollment
399 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma